Y-mAbs Therapeutics, Inc (NASDAQ:YMAB)

51.23
Delayed Data
As of 3:59pm ET
 +0.47 / +0.93%
Today’s Change
14.16
Today|||52-Week Range
55.22
+63.94%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$1.9B

Company Description

Y-mAbs Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of antibody-based therapeutic products for the treatment of cancer. Its services include discovery, protein engineering, clinical and regulatory. Y-mAbs Therapeutics was founded by Thomas Gad in April 2015 and is headquartered in New York, NY.

Contact Information

Y-mAbs Therapeutics, Inc.
230 Park Avenue
New York New York 10169
P:(646) 885-8505
Investor Relations:

Employees

Shareholders

Mutual fund holders33.61%
Individual stakeholders27.47%
Other institutional22.17%

Top Executives

Thomas GadChairman, President & Head-Business Development
Claus Juan Møller-San PedroChief Executive Officer & Director
Joris Wiel Jan WilmsChief Operating Officer & Senior Vice President
Bo KruseCFO, Secretary. Treasurer & Executive VP
Torben Lund-HansenChief Technology Officer & Senior Vice President